Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Figs Inc (FIGS) vs Stryker Corporation (SYK) Price & Performance

Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Figs Inc vs Stryker Corporation — how do they compare? Figs Inc trades at $14.28 (market cap $2.37B), while Stryker Corporation trades at $345.02 (market cap $133.54B). The key difference: Stryker Corporation is far larger — about 56.3× Figs Inc's market cap, and Stryker Corporation pays a 1.01% dividend while Figs Inc pays none. Which is the better fit depends on your goals.

FIGSSYK
Market Cap
$2.37B$133.54B
Sector
Consumer CyclicalTechnology
52-Week High
$17.12$394.34
52-Week Low
$6.57$282.58
Enterprise Value
$2.13B$145.01B
Dividend Yield
1.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Figs Inc

FIGS stock trades at $14.39, up 0.91% today, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating EPS estimates with 28.8% revenue growth, and raised its full-year outlook. Valuation remains elevated with a P/E of 43.24 and P/S of 3.83, while profitability improved with a net income margin of 8.72% in 2025.

The outlook is positive given accelerating revenue growth and margin expansion, but the rich valuation poses a risk if execution falters. Analyst consensus is bullish with a $19.50 price target, though high RSI readings suggest near-term overbought conditions. Key risks include second-half execution challenges and competitive pressures in healthcare apparel.

Stryker Corporation

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Figs Inc

FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.

Read more on FIGS

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK